ARID1B AT-rich interaction domain 1B
Model Species
Mus musculusGene Aliases
8030481M12, 9330189K18Rik, AI836955, Ardi1b, B230217J03Rik, mKIAA1235Models / Rescue Models
18 / 4Rescue Model
-Model Summary
Arid1b heterozygous mice showed social behavior impairment, altered vocalization, anxiety-like behavior, neuroanatomical abnormalities, and growth impairment. In the brain, Arid1b haploinsufficiency resulted in changes in the expression of SWI/SNF-regulated genes implicated in neuropsychiatric disorders, including deficiency in insulin-like growth factor 1. Supplementation with growth hormone restored muscle weakness and growth retardation in Arid1b heterozygous mice.
External Links
Reports related to ARID1B (6 Reports)
# | Type | Title | Author, Year |
---|---|---|---|
1 | Primary | Arid1b haploinsufficient mice reveal neuropsychiatric phenotypes and reversible causes of growth impairment. | Celen C , et al. (2017) |
2 | Additional | Arid1b Haploinsufficiency Causes Abnormal Brain Gene Expression and Autism-Related Behaviors in Mice. | Shibutani M , et al. (2017) |
3 | Additional | Arid1b haploinsufficiency disrupts cortical interneuron development and mouse behavior | Jung EM et al. (2017) |
4 | Additional | Arid1b haploinsufficiency in parvalbumin- or somatostatin-expressing interneurons leads to distinct ASD-like and ID-like behavior | Smith AL et al. (2020) |
5 | Additional | Neuroanatomy and behavior in mice with a haploinsufficiency of AT-rich interactive domain 1B (ARID1B) throughout development | Ellegood J et al. (2021) |
6 | Additional | Early postnatal serotonin modulation prevents adult-stage deficits in Arid1b-deficient mice through synaptic transcriptional reprogramming | Kim H et al. (2022) |
M_ARID1B_10_CKO_HT
Model Type: Genetic
Model Genotype: Heterozygous
Mutation:
The Arid1b-floxed allele was crossed with the PV-Cre (B6;129P2-Pvalbtm1(cre)Arbr/J; JAX 008069) allele. Exon 5 of Arid1b was floxed as in model M_ARID1B_7_KO_HT.
Allele Type: Conditional loss-of-function
Strain of Origin: C57BL6
Genetic Background: NA
Es cell line: NA
Model Source: 29184203 (Jung et al, Nat Neurosci, 2017)
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Motor phenotype | Swimming ability | No change | Morris water maze test | 2-4 months | Smith AL et al. (2020) |
Motor phenotype | Motor learning | No change | Accelerating rotarod test | 2-4 months | Smith AL et al. (2020) |
Motor phenotype | General locomotor activity: ambulatory activity | No change | Open field test | 2-4 months | Smith AL et al. (2020) |
Motor phenotype | General locomotor activity | No change | Open field test | 2-4 months | Smith AL et al. (2020) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Synapse density: inhibitory | Decreased | Western blot | 2-4 months | Smith AL et al. (2020) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Synapse density: inhibitory | Decreased | Immunohistochemistry | 2-4 months | Smith AL et al. (2020) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Synapse density: excitatory | No change | Immunohistochemistry | 2-4 months | Smith AL et al. (2020) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Brain size | No change | Measurement of tissue weight | 2-4 months | Smith AL et al. (2020) |
Repetitive behavior | Self grooming: perseveration | No change | Grooming behavior assessments | 2-4 months | Smith AL et al. (2020) |
Social behavior | Social memory | Decreased | Three-chamber social approach test | 2-4 months | Smith AL et al. (2020) |
Social behavior | Social approach | Decreased | Three-chamber social approach test | 2-4 months | Smith AL et al. (2020) |
Developmental profile | Size/growth | No change | Body weight measurement | 2-4 months | Smith AL et al. (2020) |
Emotion | Depression | Increased | Tail suspension test | 2-4 months | Smith AL et al. (2020) |
Emotion | Anxiety | Increased | Elevated plus maze test | 2-4 months | Smith AL et al. (2020) |
Emotion | Anxiety | Increased | Open field test | 2-4 months | Smith AL et al. (2020) |
Learning & memory | Swim distance | No change | Morris water maze test | 2-4 months | Smith AL et al. (2020) |
Learning & memory | Spatial working memory | No change | Morris water maze test | 2-4 months | Smith AL et al. (2020) |
Learning & memory | Spatial reference memory | No change | Morris water maze test | 2-4 months | Smith AL et al. (2020) |
Learning & memory | Object recognition memory | No change | Novel object recognition test | 2-4 months | Smith AL et al. (2020) |
Molecular profile | Targeted expression | Decreased | Immunohistochemistry | 2-4 months | Smith AL et al. (2020) |
M_ARID1B_11_CKO_HT
Model Type: Genetic
Model Genotype: Heterozygous
Mutation:
The Arid1b-floxed allele was crossed with the SST-Cre (B6N.Cg-Ssttm2.1(cre)Zjh/J; JAX 018973) allele. Exon 5 of Arid1b was floxed as in model M_ARID1B_7_KO_HT.
Allele Type: Conditional loss-of-function
Strain of Origin: C57BL6
Genetic Background: NA
Es cell line: NA
Model Source: 29184203 (Jung et al, Nat Neurosci, 2017)
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Motor phenotype | Swimming ability | No change | Morris water maze test | 2-4 months | Smith AL et al. (2020) |
Motor phenotype | Motor learning | Decreased | Accelerating rotarod test | 2-4 months | Smith AL et al. (2020) |
Motor phenotype | General locomotor activity: ambulatory activity | No change | Open field test | 2-4 months | Smith AL et al. (2020) |
Motor phenotype | General locomotor activity | No change | Open field test | 2-4 months | Smith AL et al. (2020) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Synapse density: inhibitory | Decreased | Western blot | 2-4 months | Smith AL et al. (2020) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Synapse density: inhibitory | Decreased | Immunohistochemistry | 2-4 months | Smith AL et al. (2020) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Synapse density: excitatory | No change | Immunohistochemistry | 2-4 months | Smith AL et al. (2020) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Brain size | No change | Measurement of tissue weight | 2-4 months | Smith AL et al. (2020) |
Repetitive behavior | Self grooming: perseveration | Increased | Grooming behavior assessments | 2-4 months | Smith AL et al. (2020) |
Social behavior | Social memory | No change | Three-chamber social approach test | 2-4 months | Smith AL et al. (2020) |
Social behavior | Social approach | No change | Three-chamber social approach test | 2-4 months | Smith AL et al. (2020) |
Developmental profile | Size/growth | No change | Body weight measurement | 2-4 months | Smith AL et al. (2020) |
Emotion | Depression | No change | Tail suspension test | 2-4 months | Smith AL et al. (2020) |
Emotion | Anxiety | No change | Elevated plus maze test | 2-4 months | Smith AL et al. (2020) |
Emotion | Anxiety | No change | Open field test | 2-4 months | Smith AL et al. (2020) |
Learning & memory | Swim distance | No change | Morris water maze test | 2-4 months | Smith AL et al. (2020) |
Learning & memory | Spatial working memory | Decreased | Morris water maze test | 2-4 months | Smith AL et al. (2020) |
Learning & memory | Spatial reference memory | Decreased | Morris water maze test | 2-4 months | Smith AL et al. (2020) |
Learning & memory | Object recognition memory | Decreased | Novel object recognition test | 2-4 months | Smith AL et al. (2020) |
Molecular profile | Targeted expression | Decreased | Immunohistochemistry | 2-4 months | Smith AL et al. (2020) |
M_ARID1B_12_KO_HM
Model Type: Genetic
Model Genotype: Homozygous
Mutation:
Targeting of Arid1b exon 5 employed Cas9 nuclease (D10A) and single-guide RNAs with spacer sequences for targeting exon 5, resulting in deletion of Chr17.
Allele Type: Knockout
Strain of Origin: C57BL/6NCrl
Genetic Background: C57BL/6N
Es cell line: NA
Model Source: Toronto Centre for Phenogenomics
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Developmental profile | Mortality/lethality: embryonic | Increased | General observations | E1-E10 | Ellegood J et al. (2021) |
Molecular profile | Targeted expression | Decreased | Western blot | P0 | Kim H et al. (2022) |
M_ARID1B_13_KO_HT
Model Type: Genetic
Model Genotype: Heterozygous
Mutation:
Targeting of Arid1b exon 5 employed Cas9 nuclease (D10A) and single-guide RNAs with spacer sequences for targeting exon 5, resulting in deletion of Chr17.
Allele Type: Knockout
Strain of Origin: C57BL/6NCrl
Genetic Background: C57BL/6N
Es cell line: NA
Model Source: Toronto Centre for Phenogenomics
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Motor phenotype | General locomotor activity: ambulatory activity | No change | Open field test | 2-3 months | Kim H et al. (2022) |
Motor phenotype | Spinal reflex | Decreased | General observations | P2-12 | Ellegood J et al. (2021) |
Motor phenotype | Righting response | No change | Righting reflex test | P2-12 | Ellegood J et al. (2021) |
Motor phenotype | Negative Geotaxis | Decreased | Negative geotaxis test | P2-12 | Ellegood J et al. (2021) |
Motor phenotype | Motor coordination and balance | Decreased | General observations | P2-12 | Ellegood J et al. (2021) |
Motor phenotype | Limb Posture | No change | General observations | Adult | Ellegood J et al. (2021) |
Motor phenotype | Hypoactivity | Increased | Open field test | Adult | Ellegood J et al. (2021) |
Motor phenotype | Grip strength | Decreased | Grip strength test | 17 weeks | Ellegood J et al. (2021) |
Motor phenotype | General locomotor activity: Ambulatory activity | Decreased | Open field test | Adult, 11 weeks | Ellegood J et al. (2021) |
Motor phenotype | General locomotor activity | Decreased | Distance traveled in a grid | P2-12 | Ellegood J et al. (2021) |
Motor phenotype | Gait | No change | Footprint analysis | Adult | Ellegood J et al. (2021) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Synaptic morphology: synaptic cleft length | No change | Electron microscopy | 3 weeks | Kim H et al. (2022) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Synapse density: Inhibitory | No change | Electron microscopy | 2 months | Kim H et al. (2022) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Synapse density | Decreased | Electron microscopy | 3 weeks | Kim H et al. (2022) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Size of cerebral ventricles: third ventricle | No change | Histology | 6 weeks | Kim H et al. (2022) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Size of cerebral ventricles: lateral ventricle | Increased | Histology | 6 weeks | Kim H et al. (2022) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Post-synaptic density size | No change | Electron microscopy | 3 weeks | Kim H et al. (2022) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number: Inhibitory neurons | No change | In situ hybridization (ISH) | P7, P14, P56 | Kim H et al. (2022) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number | No change | Immunohistochemistry | 6 weeks | Kim H et al. (2022) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Morphology and size of the corpus callosum | Decreased | Histology | 6 weeks | Kim H et al. (2022) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Dendritic architecture: dendritic tree complexity | Increased | Sholl analysis | 6 weeks | Kim H et al. (2022) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Cortical thickness | No change | Histology | 6 weeks | Kim H et al. (2022) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Cortical lamination | No change | Immunohistochemistry | 6 weeks | Kim H et al. (2022) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Brain morphology | No change | Histology | 6 weeks | Kim H et al. (2022) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Size of cerebral ventricles: Lateral ventricle | Increased | Histology | P0-P21 | Ellegood J et al. (2021) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Olfactory bulb morphology | Decreased | Magnetic resonance imaging (MRI) | Adult | Ellegood J et al. (2021) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neocortex morphology | Decreased | Magnetic resonance imaging (MRI) | Adult | Ellegood J et al. (2021) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Morphology of the basal ganglia: Striatum: Caudoputamen | Decreased | Magnetic resonance imaging (MRI) | Adult | Ellegood J et al. (2021) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Morphology of telencephalon | Decreased | Magnetic resonance imaging (MRI) | Adult | Ellegood J et al. (2021) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Morphology and size of the corpus callosum | Decreased | Magnetic resonance imaging (MRI) | Adult | Ellegood J et al. (2021) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Hydrocephaly | Increased | Histology | P0-P21 | Ellegood J et al. (2021) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Hippocampal morphology | Increased | Magnetic resonance imaging (MRI) | P2-2 months | Ellegood J et al. (2021) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Cerebellar morphology | Decreased | Magnetic resonance imaging (MRI) | P2-2 months | Ellegood J et al. (2021) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Brain size | Decreased | Macroscopic analysis | P2-12, adult | Ellegood J et al. (2021) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Brain morphology | Abnormal | Magnetic resonance imaging (MRI) | P2-2 months, Adult | Ellegood J et al. (2021) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Brain anatomy | Decreased | Magnetic resonance imaging (MRI) | Adult | Ellegood J et al. (2021) |
Neurophysiology | Synaptic transmission: inhibitory | No change | Whole-cell patch clamp | 2 months | Kim H et al. (2022) |
Neurophysiology | Presynaptic function: paired-pulse facilitation | No change | Whole-cell patch clamp | 2 months | Kim H et al. (2022) |
Neurophysiology | Miniature post synaptic current frequency: inhibitory | No change | Whole-cell patch clamp | 3 weeks | Kim H et al. (2022) |
Neurophysiology | Miniature post synaptic current frequency: excitatory | Decreased | Whole-cell patch clamp | 3 weeks | Kim H et al. (2022) |
Neurophysiology | Miniature post synaptic current amplitude: inhibitory | No change | Whole-cell patch clamp | 3 weeks | Kim H et al. (2022) |
Neurophysiology | Miniature post synaptic current amplitude: excitatory | No change | Whole-cell patch clamp | 3 weeks | Kim H et al. (2022) |
Neurophysiology | Membrane potential | No change | Whole-cell patch clamp | 2 months | Kim H et al. (2022) |
Neurophysiology | Intrinsic membrane properties | No change | Whole-cell patch clamp | 2 months | Kim H et al. (2022) |
Neurophysiology | Action potential property: threshold | No change | Whole-cell patch clamp | 2 months | Kim H et al. (2022) |
Neurophysiology | Action potential property: firing rate | No change | Whole-cell patch clamp | 2 months | Kim H et al. (2022) |
Repetitive behavior | Self grooming | Increased | Home cage behavior | 2-3 months | Kim H et al. (2022) |
Repetitive behavior | Vertical jumping or back flipping | Decreased | Open field test | Adult | Ellegood J et al. (2021) |
Repetitive behavior | Self grooming | No change | Grooming behavior assessments | 15 weeks | Ellegood J et al. (2021) |
Repetitive behavior | Circling | No change | Novel cage test | Adult | Ellegood J et al. (2021) |
Seizure | Seizures | Increased | Observation of chemically induced seizures | 18-19 weeks | Ellegood J et al. (2021) |
Sensory | Core body temperature | No change | Body temperature measurement | PND2-14 | Ellegood J et al. (2021) |
Social behavior | Social memory | No change | Three-chamber social approach test | 2-3 months | Kim H et al. (2022) |
Social behavior | Social interaction | Decreased | Reciprocal social interaction test | 2-3 months | Kim H et al. (2022) |
Social behavior | Social approach | No change | Three-chamber social approach test | 2-3 months | Kim H et al. (2022) |
Social behavior | Social interaction: opposite sex | Decreased | Reciprocal social interaction test | 16 weeks | Ellegood J et al. (2021) |
Social behavior | Social approach | No change | Three-chamber social approach test | 15 weeks | Ellegood J et al. (2021) |
Social behavior | Allogrooming | No change | Grooming behavior assessments | 15 weeks | Ellegood J et al. (2021) |
Communications | Ultrasonic vocalization: Isolation induced | Decreased | Monitoring ultrasonic vocalizations | P3-11 | Kim H et al. (2022) |
Communications | Ultrasonic vocalization: Isolation induced | Decreased | Monitoring ultrasonic vocalizations | PND2-14 | Ellegood J et al. (2021) |
Communications | Ultrasonic vocalization: Interaction induced: opposite sex stimulus | Decreased | Monitoring ultrasonic vocalizations | Adult | Ellegood J et al. (2021) |
Developmental profile | Size/growth | Decreased | Body weight measurement | P3-P49 | Kim H et al. (2022) |
Developmental profile | Mortality/lethality | No change | General observations | P0 | Kim H et al. (2022) |
Developmental profile | Size/growth | Decreased | Body weight measurement | P2-12, Adult | Ellegood J et al. (2021) |
Developmental profile | Size/growth | Decreased | Body length measurement | P2-12 | Ellegood J et al. (2021) |
Developmental profile | Developmental trajectory | Decreased | General observations | P2-P14 | Ellegood J et al. (2021) |
Emotion | Exploratory activity | Decreased | Novel object recognition test | 2-3 months | Kim H et al. (2022) |
Emotion | Anxiety | No change | Open field test | 2-3 months | Kim H et al. (2022) |
Emotion | Anxiety | No change | Elevated plus maze test | 2-3 months | Kim H et al. (2022) |
Emotion | Anxiety | No change | Light-dark exploration test | 2-3 months | Kim H et al. (2022) |
Emotion | Exploratory activity: Habituation | No change | Open field test | Adult | Ellegood J et al. (2021) |
Emotion | Anxiety | Increased | Elevated plus maze test | 10 weeks | Ellegood J et al. (2021) |
Emotion | Anxiety | No change | Light-dark exploration test | 10 weeks | Ellegood J et al. (2021) |
Learning & memory | Object recognition memory | No change | Novel object recognition test | 2-3 months | Kim H et al. (2022) |
Learning & memory | Visual discrimination learning | Increased | Operant self-learning paradigm | 9-17 weeks | Ellegood J et al. (2021) |
Learning & memory | Object recognition memory | Decreased | Novel object recognition test | 13 weeks | Ellegood J et al. (2021) |
Learning & memory | Cued or contextual fear conditioning: Memory of cue | No change | Fear conditioning test | 18 weeks | Ellegood J et al. (2021) |
Learning & memory | Cued or contextual fear conditioning: Memory of context | No change | Fear conditioning test | 18 weeks | Ellegood J et al. (2021) |
Learning & memory | Cognitive flexibility | No change | Operant self-learning paradigm | 12 weeks | Ellegood J et al. (2021) |
Molecular profile | Targeted expression | Decreased | Western blot | P0 | Kim H et al. (2022) |
Molecular profile | Protein phosphorylation | Decreased | Western blot | 3-6 months | Kim H et al. (2022) |
Molecular profile | Protein expression level evidence | Decreased | Western blot | 3-6 months | Kim H et al. (2022) |
Molecular profile | Protein expression level evidence | Increased | Western blot | 3-6 months | Kim H et al. (2022) |
Molecular profile | Differential gene expression: ASD risk genes | Abnormal | RNA sequencing | P3-P10 | Kim H et al. (2022) |
Molecular profile | Differential gene expression | Abnormal | RNA sequencing | P3-P10 | Kim H et al. (2022) |
Molecular profile | Targeted expression | Decreased | Quantitative PCR (qRT-PCR) | Adult | Ellegood J et al. (2021) |
Molecular profile | Targeted expression | Decreased | Western blot | Adult | Ellegood J et al. (2021) |
Molecular profile | Differential gene expression | Abnormal | RNA sequencing | 5 months | Ellegood J et al. (2021) |
M_ARID1B_13_KO_HT_FLUOXETINE
Model Type: RESCUE-Pharmaceutical
Model Genotype: Heterozygous
Mutation:
Treated with Fluoxetine at P3-P21
Allele Type: Knockout
Strain of Origin: C57BL/6NCrl
Genetic Background: C57BL/6N
Es cell line: -
Model Source: Toronto Centre for Phenogenomics
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Motor phenotype | General locomotor activity: ambulatory activity | Side effect | Open field test | 2-3 months | Kim H et al. (2022) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Synaptic morphology: synaptic cleft length | No adverse effect | Electron microscopy | 3-6 months | Kim H et al. (2022) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Synapse density | Restored | Electron microscopy | 3 months | Kim H et al. (2022) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Post-synaptic density size | No adverse effect | Electron microscopy | 3-6 months | Kim H et al. (2022) |
Neurophysiology | Presynaptic function: paired-pulse facilitation | No adverse effect | Whole-cell patch clamp | 3 months | Kim H et al. (2022) |
Neurophysiology | Neurotransmitter release: serotonin | No change | Liquid chromatography-mass spectrometry (LC-MS) | 3-6 months | Kim H et al. (2022) |
Neurophysiology | Miniature post synaptic current frequency: excitatory | Restored | Whole-cell patch clamp | 3 months | Kim H et al. (2022) |
Neurophysiology | Miniature post synaptic current amplitude: excitatory | No adverse effect | Whole-cell patch clamp | 3 months | Kim H et al. (2022) |
Repetitive behavior | Self grooming | Restored | Home cage behavior | 2-3 months | Kim H et al. (2022) |
Social behavior | Social interaction | Ameliorated | Reciprocal social interaction test | 2-3 months | Kim H et al. (2022) |
Developmental profile | Size/growth | Refractory | Body weight measurement | 2-3 months | Kim H et al. (2022) |
Emotion | Depression | No change | Forced swim test | 3-6 months | Kim H et al. (2022) |
Emotion | Anxiety | No adverse effect | Open field test | 2-3 months | Kim H et al. (2022) |
Molecular profile | Protein phosphorylation | Restored | Western blot | 3-6 months | Kim H et al. (2022) |
Molecular profile | Protein expression level evidence | Restored | Western blot | 3-6 months | Kim H et al. (2022) |
Molecular profile | Differential gene expression | Ameliorated | RNA sequencing | 4 months | Kim H et al. (2022) |
M_ARID1B_14_CKO_HT
Model Type: Genetic
Model Genotype: Heterozygous
Mutation:
Mice harboring a cassette containing the Ardi1b gene flanked by loxP and lacZ sites flanked by FRT sites were obtained from EUCOMM. This Arid1b^tm1a(EUCOMM)Hmgu mouse line was crossed with Protamine-Flp mice to remove the cassette and produce Arid1bfl/+ mice. Sert-Cre; Arid1b^fl/+ mice were generated by crossing Sert-Cre female mice from Jackson Laboratory (B6.129(Cg)-Slc6a4^tm1(cre)Xz/J) with Arid1b^fl/fl male mice.
Allele Type: Conditional knockout
Strain of Origin: C57BL/6N; 129S1/Sv-Oca2+ Tyr+ Kitl+
Genetic Background: C57BL/6J
Es cell line: JM8.N4; W9.5/W95
Model Source: Helmholtz Zentrum Muenchen GmbH; Xiaoxi Zhuang
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Repetitive behavior | Self grooming | No change | Home cage behavior | 6 weeks | Kim H et al. (2022) |
Social behavior | Social interaction | No change | Reciprocal social interaction test | 6 weeks | Kim H et al. (2022) |
M_ARID1B_1_KO_HT
Model Type: Genetic
Model Genotype: Heterozygous
Mutation:
Cas9 germline gene-editing was used to flox exon5 of Arid1b and generate whole-body Arid1b knockout mice with a deleted exon 5.
Allele Type: Knockout
Strain of Origin: C57BL/6J
Genetic Background: -
Es cell line: -
Model Source: -
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Motor phenotype | Grip strength | Decreased | Grip strength test | Not reported | Celen C , et al. (2017) |
Motor phenotype | General locomotor activity: ambulatory activity | No change | Open field test | 8 weeks | Celen C , et al. (2017) |
Motor phenotype | General locomotor activity: ambulatory activity | No change | Light-dark exploration test | 8 weeks | Celen C , et al. (2017) |
Motor phenotype | General locomotor activity: ambulatory activity | No change | Elevated plus maze test | 8 weeks | Celen C , et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number | Decreased | Immunohistochemistry | P0-10 | Celen C , et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Morphology and size of the corpus callosum | Decreased | Immunohistochemistry | 1.7 months | Celen C , et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Morphology and size of the corpus callosum | Decreased | Histology | Not reported | Celen C , et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Hippocampal morphology | Decreased | Immunohistochemistry | 1.7 months | Celen C , et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Cortical thickness | Decreased | Immunohistochemistry | P0-10 | Celen C , et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Cell proliferation: neural precursors | Decreased | Immunohistochemistry | 1.7 months | Celen C , et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Brain size | No change | Gross necroscopy | P0-10 | Celen C , et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Brain development | Decreased | Gross necroscopy | Not reported | Celen C , et al. (2017) |
Neurophysiology | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Repetitive behavior | Self grooming: perseveration | Increased | Grooming behavior assessments | Adult | Celen C , et al. (2017) |
Repetitive behavior | Repetitive digging | Decreased | Marble-burying test | Not reported | Celen C , et al. (2017) |
Seizure | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Sensory | Pain or nociception | No change | Foot shock test | 8 weeks | Celen C , et al. (2017) |
Social behavior | Social interaction: with juveniles | Decreased | Reciprocal social interaction test | Adult | Celen C , et al. (2017) |
Physiological parameters | Satiety response | No change | Food intake measurements | 1.9 weeks | Celen C , et al. (2017) |
Physiological parameters | Renal function | No change | Urine/blood electrolyte analysis | 3.4 months | Celen C , et al. (2017) |
Physiological parameters | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Physiological parameters | Hormone levels | No change | Elisa | 2 weeks, 0.9-1.4 months | Celen C , et al. (2017) |
Physiological parameters | Hormone levels | No change | Elisa | 1.1-1.5 months | Celen C , et al. (2017) |
Physiological parameters | Hormone levels | Decreased | Elisa | 0.9-1.4 months | Celen C , et al. (2017) |
Physiological parameters | Homeostasis | No change | Cell counting | 3.4 months | Celen C , et al. (2017) |
Communications | Ultrasonic vocalization: isolation induced | Abnormal | Monitoring ultrasonic vocalizations | P4 | Celen C , et al. (2017) |
Communications | Audible vocalization | Decreased | General observations | Not reported | Celen C , et al. (2017) |
Developmental profile | Size/growth | Decreased | Body weight measurement | 0.9-1.2 months | Celen C , et al. (2017) |
Developmental profile | Size/growth | Decreased | Body length measurement | 0.9-1.2 months | Celen C , et al. (2017) |
Developmental profile | Renal morphology | Decreased | Gross necroscopy | P0-10 | Celen C , et al. (2017) |
Developmental profile | Mortality/lethality: neonatal | Increased | General observations | Adult | Celen C , et al. (2017) |
Developmental profile | General characteristics | No change | General observations | P0-10 | Celen C , et al. (2017) |
Developmental profile | Digestive system development | No change | Gross necroscopy | P0-10 | Celen C , et al. (2017) |
Developmental profile | Cardiovascular development and function | Decreased | Gross necroscopy | P0-10 | Celen C , et al. (2017) |
Emotion | Anxiety | Increased | Open field test | 8 weeks | Celen C , et al. (2017) |
Emotion | Anxiety | Increased | Light-dark exploration test | 8 weeks | Celen C , et al. (2017) |
Emotion | Anxiety | Increased | Elevated plus maze test | 8 weeks | Celen C , et al. (2017) |
Immune response | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Learning & memory | Spatial working memory | No change | Morris water maze test | 2 weeks | Celen C , et al. (2017) |
Learning & memory | Spatial reference memory | No change | Morris water maze test | 2 weeks | Celen C , et al. (2017) |
Learning & memory | Cued or contextual fear conditioning: memory of cue | No change | Fear conditioning test | 8 weeks | Celen C , et al. (2017) |
Learning & memory | Cued or contextual fear conditioning: memory of context | No change | Fear conditioning test | 8 weeks | Celen C , et al. (2017) |
Maternal behavior | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Molecular profile | Targeted expression | Decreased | Western blot | Not reported | Celen C , et al. (2017) |
Molecular profile | Protein-dna complex assembly | Increased | Chromatin immunoprecipitation (chip) | 2.6-2.7 months | Celen C , et al. (2017) |
Molecular profile | Gene expression | Abnormal | Rna sequencing | 2.6-2.7 months | Celen C , et al. (2017) |
Molecular profile | Gene expression | No change | Quantitative pcr (qrt-pcr) | 1.1-1.5 months | Celen C , et al. (2017) |
Molecular profile | Gene expression | No change | Quantitative pcr (qrt-pcr) | 1.1-1.5 months | Celen C , et al. (2017) |
Molecular profile | Gene expression | Increased | Quantitative pcr (qrt-pcr) | 1.4 months | Celen C , et al. (2017) |
Molecular profile | Gene expression | Decreased | Quantitative pcr (qrt-pcr) | 1.4 months | Celen C , et al. (2017) |
Molecular profile | Enzyme activity | No change | Enzyme assay | 3.4 months | Celen C , et al. (2017) |
M_ARID1B_1_KO_HT_RHIGF1
Model Type: RESCUE-Pharmaceutical
Model Genotype: Heterozygous
Mutation:
Arid1b heterozygous knockouts were treated with 0.5mg/kg recombinant human IGF1 (rhIGF1) daily from P11 to 2 months.
Allele Type: Knockout
Strain of Origin: C57BL/6J
Genetic Background: -
Es cell line: -
Model Source: -
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Motor phenotype | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Neurophysiology | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Repetitive behavior | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Seizure | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Sensory | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Social behavior | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Physiological parameters | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Communications | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Developmental profile | Size/growth | Refractory | Body weight measurement | 1.7 months | Celen C , et al. (2017) |
Emotion | Anxiety | Refractory | Elevated plus maze test | 1.7 months | Celen C , et al. (2017) |
Immune response | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Learning & memory | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Maternal behavior | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Molecular profile | NA | Not reported | NA | NA | Celen C , et al. (2017) |
M_ARID1B_1_KO_HT_RMGH
Model Type: RESCUE-Pharmaceutical
Model Genotype: Heterozygous
Mutation:
Arid1b heterozygous knockouts were subcutaneously injected with 30microgram recombinant mouse growth hormone (rmGH) daily between postnatal day 11 and 14 and 50micrgram rmGH daily between postnatal day 14 and 21, and 70micrgram rmGH daily between postnatal day 21 and 50.
Allele Type: Knockout
Strain of Origin: C57BL/6J
Genetic Background: -
Es cell line: -
Model Source: -
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Motor phenotype | Grip strength | Restored | Grip strength test | 2 months | Celen C , et al. (2017) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Neurophysiology | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Repetitive behavior | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Seizure | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Sensory | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Social behavior | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Physiological parameters | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Communications | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Developmental profile | Size/growth | Ameliorated | Body weight measurement | 1.7 months | Celen C , et al. (2017) |
Developmental profile | Size/growth | Ameliorated | Body length measurement | 1.7 months | Celen C , et al. (2017) |
Emotion | Anxiety | Refractory | Elevated plus maze test | 1.7 months | Celen C , et al. (2017) |
Immune response | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Learning & memory | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Maternal behavior | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Molecular profile | NA | Not reported | NA | NA | Celen C , et al. (2017) |
M_ARID1B_2_KO_HM
Model Type: Genetic
Model Genotype: Homozygous
Mutation:
Cas9 germline gene-editing was used to flox exon5 of Arid1b and generate whole-body Arid1b knockout mice with a deleted exon 5.
Allele Type: Knockout
Strain of Origin: C57BL/6J
Genetic Background: -
Es cell line: -
Model Source: -
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Motor phenotype | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number | Decreased | Immunohistochemistry | P0-10 | Celen C , et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Cortical thickness | Decreased | Immunohistochemistry | P0-10 | Celen C , et al. (2017) |
Neurophysiology | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Repetitive behavior | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Seizure | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Sensory | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Social behavior | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Physiological parameters | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Communications | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Developmental profile | Mortality/lethality: neonatal | Increased | General observations | P0-10 | Celen C , et al. (2017) |
Emotion | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Immune response | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Learning & memory | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Maternal behavior | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Molecular profile | Targeted expression | Decreased | Western blot | P0 | Celen C , et al. (2017) |
M_ARID1B_3_CKO_HT
Model Type: Genetic
Model Genotype: Heterozygous
Mutation:
Conditional heterozygous deletion of exon 5 (floxed allele generated by Cas9 mediated editing) of the Arid1b gene using Albumin-cre, in the liver
Allele Type: Conditional loss-of-function
Strain of Origin: C57BL/6J
Genetic Background: -
Es cell line: -
Model Source: -
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Motor phenotype | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Neurophysiology | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Repetitive behavior | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Seizure | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Sensory | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Social behavior | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Physiological parameters | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Physiological parameters | Hormone levels | No change | Elisa | 1.4-1.5 months | Celen C , et al. (2017) |
Communications | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Developmental profile | Size/growth | No change | Body weight measurement | 1.1-3.1 weeks | Celen C , et al. (2017) |
Emotion | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Immune response | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Learning & memory | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Maternal behavior | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Molecular profile | NA | Not reported | NA | NA | Celen C , et al. (2017) |
M_ARID1B_4_CKO_HT
Model Type: Genetic
Model Genotype: Heterozygous
Mutation:
Conditional heterozygous deletion of exon 5 (floxed allele generated by Cas9 mediated editing) of the Arid1b gene using Nestin-cre, in neuronal, glial and other cell types in the central and peripheral nervous system
Allele Type: Conditional loss-of-function
Strain of Origin: C57BL/6J
Genetic Background: -
Es cell line: -
Model Source: -
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Motor phenotype | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Neurophysiology | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Repetitive behavior | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Seizure | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Sensory | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Social behavior | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Physiological parameters | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Physiological parameters | Hormone levels | Decreased | Elisa | 1.4-1.5 months | Celen C , et al. (2017) |
Physiological parameters | Hormone levels | Decreased | Elisa | Not reported | Celen C , et al. (2017) |
Communications | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Developmental profile | Size/growth | Decreased | Body weight measurement | 1.1-5 weeks | Celen C , et al. (2017) |
Emotion | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Immune response | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Learning & memory | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Maternal behavior | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Molecular profile | NA | Not reported | NA | NA | Celen C , et al. (2017) |
M_ARID1B_5_CKO_HT
Model Type: Genetic
Model Genotype: Heterozygous
Mutation:
Conditional heterozygous deletion of exon 5 (floxed allele generated by Cas9 mediated editing) of the Arid1b gene using Ckm-Cre, in skeletal muscle
Allele Type: Conditional loss-of-function
Strain of Origin: C57BL/6J
Genetic Background: -
Es cell line: -
Model Source: -
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Motor phenotype | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Neuroanatomy / ultrastructure / cytoarchitecture | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Neurophysiology | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Repetitive behavior | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Seizure | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Sensory | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Social behavior | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Physiological parameters | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Communications | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Developmental profile | Size/growth | No change | Body weight measurement | 1.1-3.1 weeks | Celen C , et al. (2017) |
Developmental profile | General characteristics | No change | General observations | Not reported | Celen C , et al. (2017) |
Emotion | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Immune response | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Learning & memory | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Maternal behavior | NA | Not reported | NA | NA | Celen C , et al. (2017) |
Molecular profile | NA | Not reported | NA | NA | Celen C , et al. (2017) |
M_ARID1B_6_KO_HT
Model Type: Genetic
Model Genotype: Heterozygous
Mutation:
CRISPR/Cas9 double-nicking method of gene editing was used to generate a deletion in exon 3.
Allele Type: Knockout
Strain of Origin: C57BL/6J
Genetic Background: -
Es cell line: -
Model Source: -
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Circadian sleep/wake cycle | NA | Not reported | NA | NA | Shibutani M , et al. (2017) |
Motor phenotype | Motor coordination and balance | Decreased | Balance beam test | 16-19 weeks | Shibutani M , et al. (2017) |
Motor phenotype | Motor coordination and balance | Decreased | Accelerating rotarod test | 12-15 weeks | Shibutani M , et al. (2017) |
Motor phenotype | Grip strength | Decreased | Wire hang test | 1013 weeks | Shibutani M , et al. (2017) |
Motor phenotype | General locomotor activity: ambulatory activity | Decreased | Elevated plus maze test | 11-14 weeks | Shibutani M , et al. (2017) |
Motor phenotype | General locomotor activity: ambulatory activity | No change | Light-dark exploration test | 10-13 weeks | Shibutani M , et al. (2017) |
Motor phenotype | General locomotor activity: ambulatory activity | Decreased | Open field test | 11-13 weeks | Shibutani M , et al. (2017) |
Motor phenotype | General locomotor activity | No change | Reciprocal social interaction test | 12-14 weeks | Shibutani M , et al. (2017) |
Motor phenotype | General locomotor activity | Decreased | Reciprocal social interaction test | 39-42 weeks | Shibutani M , et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Brain development | Abnormal | General observations | 8-12 weeks | Shibutani M , et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Brain cytoarchitecture | No change | Histology | 8-9 weeks | Shibutani M , et al. (2017) |
Neurophysiology | NA | Not reported | NA | NA | Shibutani M , et al. (2017) |
Repetitive behavior | Circling | Decreased | Open field test | 11-13 weeks | Shibutani M , et al. (2017) |
Seizure | NA | Not reported | NA | NA | Shibutani M , et al. (2017) |
Sensory | Startle response: acoustic stimulus | Decreased | Startle response test | 13-16 weeks | Shibutani M , et al. (2017) |
Sensory | Startle response: acoustic stimulus | No change | Startle response test | 13-16 weeks | Shibutani M , et al. (2017) |
Sensory | Sensorimotor gating | No change | Prepulse inhibition | 13-16 weeks | Shibutani M , et al. (2017) |
Sensory | Sensorimotor gating | Decreased | Prepulse inhibition | 13-16 weeks | Shibutani M , et al. (2017) |
Sensory | Pain or nociception | No change | Hot plate test | 12-14 weeks | Shibutani M , et al. (2017) |
Sensory | Foot shock sensitivity | Decreased | Fear conditioning test | 33-36 weeks | Shibutani M , et al. (2017) |
Social behavior | Social memory | No change | Three-chamber social approach test | 13-15 weeks | Shibutani M , et al. (2017) |
Social behavior | Social interaction | No change | Reciprocal social interaction test | 12-14 weeks | Shibutani M , et al. (2017) |
Social behavior | Social interaction | Increased | Reciprocal social interaction test | 39-42 weeks | Shibutani M , et al. (2017) |
Social behavior | Social approach | No change | Three-chamber social approach test | 13-15 weeks | Shibutani M , et al. (2017) |
Physiological parameters | NA | Not reported | NA | NA | Shibutani M , et al. (2017) |
Physiological parameters | Core body temperature | No change | Body temperature measurement | 10-13 weeks | Shibutani M , et al. (2017) |
Communications | NA | Not reported | NA | NA | Shibutani M , et al. (2017) |
Developmental profile | Size/growth | Decreased | Body weight measurement | 10-13 weeks | Shibutani M , et al. (2017) |
Emotion | Depression | Decreased | Forced swim test | 13-16 weeks | Shibutani M , et al. (2017) |
Emotion | Anxiety | No change | Light-dark exploration test | 10-13 weeks | Shibutani M , et al. (2017) |
Emotion | Anxiety | No change | Open field test | 11-13 weeks | Shibutani M , et al. (2017) |
Emotion | Anxiety | Increased | Elevated plus maze test | 11-14 weeks | Shibutani M , et al. (2017) |
Immune response | NA | Not reported | NA | NA | Shibutani M , et al. (2017) |
Learning & memory | Spatial reference memory | Increased | Barnes maze test | 16-23 weeks | Shibutani M , et al. (2017) |
Learning & memory | Spatial learning | No change | Barnes maze test | 16-23 weeks | Shibutani M , et al. (2017) |
Learning & memory | Cued or contextual fear conditioning: memory of cue: long term recall | Increased | Fear conditioning test | 33-40 weeks | Shibutani M , et al. (2017) |
Learning & memory | Cued or contextual fear conditioning: memory of cue | No change | Fear conditioning test | 33-40 weeks | Shibutani M , et al. (2017) |
Learning & memory | Cued or contextual fear conditioning: memory of context: long term recall | No change | Fear conditioning test | 33-40 weeks | Shibutani M , et al. (2017) |
Learning & memory | Cued or contextual fear conditioning: memory of context | No change | Fear conditioning test | 33-40 weeks | Shibutani M , et al. (2017) |
Learning & memory | Cognitive flexibility | Decreased | Barnes maze test | 16-23 weeks | Shibutani M , et al. (2017) |
Maternal behavior | NA | Not reported | NA | NA | Shibutani M , et al. (2017) |
Molecular profile | Targeted expression | Decreased | Western blot | Not reported | Shibutani M , et al. (2017) |
Molecular profile | Gene expression | Decreased | Rna sequencing | Not reported | Shibutani M , et al. (2017) |
Molecular profile | Gene expression | Decreased | Rna sequencing | Not reported | Shibutani M , et al. (2017) |
Molecular profile | Gene expression | Decreased | Quantitative pcr (qrt-pcr) | Not reported | Shibutani M , et al. (2017) |
M_ARID1B_7_KO_HT
Model Type: Genetic
Model Genotype: Heterozygous
Mutation:
Exon 5 of the Arid1b gene was flanked by loxp sites to create a deletion allele. To generate the global Arid1b KO allele, the knockout first allele was crossed with a CMV-Cre mouse strain (Jackson Llaboratory, #006054), and the resulting Arid1b KO allele in which the neo cassette, one FRT, one loxP, and exon 5 were removed was selected by genomic PCR and sequencing. Lack of Arid1b protein in the null mice was confirmed.
Allele Type: Knockout
Strain of Origin: C57BL6
Genetic Background: NA
Es cell line: NA
Model Source: NA
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Motor phenotype | Swimming ability | No change | Morris water maze test | 3-4 months | Jung EM et al. (2017) |
Motor phenotype | Motor learning | Decreased | Accelerating rotarod test | 3-4 months | Jung EM et al. (2017) |
Motor phenotype | General locomotor activity: ambulatory activity | Decreased | Open field test | 3-4 months | Jung EM et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Synaptic neuroreceptors | Decreased | Quantitative pcr (qrt-pcr) | 3 months | Jung EM et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Synaptic morphology: synaptic cleft length | Increased | Electron microscopy | 3 months | Jung EM et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Synapse density: inhibitory | Decreased | Immunohistochemistry | 3 months | Jung EM et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Synapse density: inhibitory | Decreased | Quantitative pcr (qrt-pcr) | 3 months | Jung EM et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Synapse density: inhibitory | Decreased | Western blot | 3 months | Jung EM et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Synapse density: excitatory | No change | Quantitative pcr (qrt-pcr) | 3 months | Jung EM et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Synapse density: excitatory | No change | Immunohistochemistry | 3 months | Jung EM et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Synapse density: excitatory | No change | Quantitative pcr (qrt-pcr) | 3 months | Jung EM et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Post-synaptic density size: inhibitory synapses | Decreased | Electron microscopy | 3 months | Jung EM et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuroreceptor levels: gaba-r: gabaa | No change | Quantitative pcr (qrt-pcr) | 3 months | Jung EM et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number: interneurons | No change | Immunohistochemistry | 1month; 3 months | Jung EM et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number: interneurons | Decreased | Quantitative pcr (qrt-pcr) | 3 months | Jung EM et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number: inhibitory neurons | Decreased | Immunohistochemistry | 1month; 3 months | Jung EM et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number: excitatory neurons | No change | Immunohistochemistry | 1 month, 3 months | Jung EM et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number | No change | Immunohistochemistry | 1 month, 3 months | Jung EM et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Glial number | No change | Immunohistochemistry | 1month; 3 months | Jung EM et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Cortical lamination | Abnormal | Immunohistochemistry | 1 month, 3 months | Jung EM et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Cell proliferation: neural precursors | Decreased | Immunohistochemistry | E12.5 | Jung EM et al. (2017) |
Neurophysiology | Miniature post synaptic current frequency: inhibitory | Decreased | Whole-cell patch clamp | 3-4 months | Jung EM et al. (2017) |
Neurophysiology | Miniature post synaptic current frequency: excitatory | No change | Whole-cell patch clamp | 3-4 months | Jung EM et al. (2017) |
Neurophysiology | Miniature post synaptic current amplitude: inhibitory | No change | Whole-cell patch clamp | 3-4 months | Jung EM et al. (2017) |
Neurophysiology | Miniature post synaptic current amplitude: excitatory | No change | Whole-cell patch clamp | 3-4 months | Jung EM et al. (2017) |
Neurophysiology | Apoptosis: brain cells | Increased | Immunohistochemistry | E12.5 | Jung EM et al. (2017) |
Repetitive behavior | Self grooming: perseveration | Increased | Grooming behavior assessments | 3-4 months | Jung EM et al. (2017) |
Social behavior | Social memory | Decreased | Three-chamber social approach test | 3-4 months | Jung EM et al. (2017) |
Social behavior | Social interaction | Decreased | Reciprocal social interaction test | 3-4 months | Jung EM et al. (2017) |
Social behavior | Social approach | Decreased | Three-chamber social approach test | 3-4 months | Jung EM et al. (2017) |
Developmental profile | Size/growth | Decreased | Body weight measurement | P14, 21, 28, 56 and 63 | Jung EM et al. (2017) |
Emotion | Depression | Increased | Forced swim test | 3-4 months | Jung EM et al. (2017) |
Emotion | Anxiety | Increased | Elevated plus maze test | 3-4 months | Jung EM et al. (2017) |
Emotion | Anxiety | Increased | Open field test | 3-4 months | Jung EM et al. (2017) |
Learning & memory | Swim distance | No change | Morris water maze test | 3-4 months | Jung EM et al. (2017) |
Learning & memory | Spatial working memory | Decreased | Morris water maze test | 3-4 months | Jung EM et al. (2017) |
Learning & memory | Spatial reference memory | Decreased | Morris water maze test | 3-4 months | Jung EM et al. (2017) |
Learning & memory | Reward reinforced choice behavior | Decreased | T-maze test | 3-4 months | Jung EM et al. (2017) |
Learning & memory | Object recognition memory | Decreased | Novel object recognition test | 3-4 months | Jung EM et al. (2017) |
Molecular profile | Targeted expression | Decreased | Quantitative pcr (qrt-pcr) | E14.5 | Jung EM et al. (2017) |
Molecular profile | Targeted expression | Decreased | Western blot | E14.5 | Jung EM et al. (2017) |
Molecular profile | Signaling: wnt pathway | Decreased | Western blot | E15.5 | Jung EM et al. (2017) |
Molecular profile | Regulation of gene expression | Decreased | Chromatin immunoprecipitation sequencing (chip-seq) | 3 months | Jung EM et al. (2017) |
Molecular profile | Protein-dna complex assembly | Decreased | Chromatin immunoprecipitation sequencing (chip-seq) | 3 months | Jung EM et al. (2017) |
Molecular profile | Protein localization: nucleus | No change | Western blot | 3 months | Jung EM et al. (2017) |
Molecular profile | Protein expression level evidence | No change | Western blot | 3 months | Jung EM et al. (2017) |
Molecular profile | Protein expression level evidence | Decreased | Western blot | 3 months | Jung EM et al. (2017) |
Molecular profile | Protein binding | Decreased | Co-immunoprecipitation | 3 months | Jung EM et al. (2017) |
Molecular profile | Protein binding | Decreased | Proximity ligation assay | 3 months | Jung EM et al. (2017) |
Molecular profile | Gene expression: wnt pathway | Decreased | Quantitative pcr (qrt-pcr) | E15.5 | Jung EM et al. (2017) |
Molecular profile | Enzyme activity | No change | Western blot | 3 months | Jung EM et al. (2017) |
Molecular profile | Chromatin modification: histone modification: open chromatin | Decreased | Western blot | 3 months | Jung EM et al. (2017) |
Molecular profile | Chromatin modification: histone acetylation | Decreased | Chromatin immunoprecipitation sequencing (chip-seq) | 3 months | Jung EM et al. (2017) |
Molecular profile | Chromatin modification | No change | Quantitative pcr (qrt-pcr) | 3 months | Jung EM et al. (2017) |
M_ARID1B_7_KO_HT_CLONAZEPAM
Model Type: RESCUE-Pharmaceutical
Model Genotype: Heterozygous
Mutation:
Arid1b heterozygous mutant mice were intraperitoneally injected with clonazepam, a positive allosteric modulator of GABAA receptor
Allele Type: Knockout
Strain of Origin: C57BL6
Genetic Background: NA
Es cell line: NA
Model Source: NA
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Motor phenotype | General locomotor activity: ambulatory activity | Restored | Open field test | 3-4 months | Jung EM et al. (2017) |
Neurophysiology | Miniature post synaptic current frequency: inhibitory | Restored | Whole-cell patch clamp | 3-4 months | Jung EM et al. (2017) |
Social behavior | Social memory | Restored | Three-chamber social approach test | 3-4 months | Jung EM et al. (2017) |
Emotion | Anxiety | Restored | Open field test | 3-4 months | Jung EM et al. (2017) |
Learning & memory | Object recognition memory | Restored | Novel object recognition test | 3-4 months | Jung EM et al. (2017) |
M_ARID1B_8_CKO_HT
Model Type: Genetic
Model Genotype: Heterozygous
Mutation:
Mice with exon 5 of Arid1b floxed were crossed with Dlx5/6-Cre-IRES-EGFP
Allele Type: Conditional loss-of-function
Strain of Origin: C57BL6
Genetic Background: NA
Es cell line: NA
Model Source: 29184203 (Jung et al, Nat Neurosci, 2017)
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Motor phenotype | General locomotor activity: ambulatory activity | Decreased | Open field test | 3-4 months | Jung EM et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number: interneurons | Decreased | Immunohistochemistry | E12.5, e14.5, e16.5 and e18.5 | Jung EM et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number: inhibitory neurons | Decreased | Immunohistochemistry | 1month; 3 months | Jung EM et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal morphology | Decreased | Immunohistochemistry | 3 months | Jung EM et al. (2017) |
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal migration | No change | Immunohistochemistry | E14.5, e18.5 | Jung EM et al. (2017) |
Repetitive behavior | Self grooming: perseveration | Increased | Grooming behavior assessments | 3-4 months | Jung EM et al. (2017) |
Social behavior | Social memory | Decreased | Three-chamber social approach test | 3-4 months | Jung EM et al. (2017) |
Social behavior | Social approach | Decreased | Three-chamber social approach test | 3-4 months | Jung EM et al. (2017) |
Emotion | Anxiety | Increased | Open field test | 3-4 months | Jung EM et al. (2017) |
Learning & memory | Object recognition memory | Decreased | Novel object recognition test | 3-4 months | Jung EM et al. (2017) |
M_ARID1B_9_CKO_HT
Model Type: Genetic
Model Genotype: Heterozygous
Mutation:
Mice with exon 5 of Arid1b floxed were crossed with Nkx2.1-Cre mouse line
Allele Type: Conditional loss-of-function
Strain of Origin: C57BL6
Genetic Background: NA
Es cell line: NA
Model Source: 29184203 (Jung et al, Nat Neurosci, 2017)
Category | Entity | Value Change | Experimental Paradigm | Age at Testing | Author, Year |
---|---|---|---|---|---|
Neuroanatomy / Ultrastructure / Cytoarchitecture | Neuronal number: inhibitory neurons | Decreased | Immunohistochemistry | 1month; 3 months | Jung EM et al. (2017) |
Repetitive behavior | Self grooming: perseveration | Increased | Grooming behavior assessments | 3-4 months | Jung EM et al. (2017) |
Other ARID1B Rescue Models(4 Models)
M_ARID1B_1_KO_HT | 1 | Genetic | Pharmaceutical | recombinant human insulin like growth factor 1 |
M_ARID1B_1_KO_HT | 1 | Genetic | Pharmaceutical | recombinant mouse growth hormone |
M_ARID1B_7_KO_HT | 1 | Genetic | Pharmaceutical | Clonazepam |
M_ARID1B_13_KO_HT | 1 | Genetic | Pharmaceutical | Fluoxetine |
CNVs associated with ARID1B(1 Models)
Sort By:
6q25.3 | 21 | Deletion-Duplication | 32 / 51 |